The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor
- 1 October 2001
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (15) , 1930-1937
- https://doi.org/10.1016/s0959-8049(01)00210-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit PhosphorylationScience, 1999
- Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear PhagocytesJournal of Biological Chemistry, 1999
- The Multisubunit IκB Kinase Complex Shows Random Sequential Kinetics and Is Activated by the C-terminal Domain of IκBαJournal of Biological Chemistry, 1998
- Immunomodulatory Actions of Xanthenone Anticancer AgentsBioDrugs, 1997
- Identification and Characterization of an IκB KinaseCell, 1997
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Stimulation of tumor necrosis factor alpha production in human monocytes by inhibitors of protein phosphatase 1 and 2A.The Journal of Experimental Medicine, 1992
- Okadaic acid is a potent inducer of AP-1, NF-κB, and tumor necrosis factor-α in human B lymphocytesBiochemical and Biophysical Research Communications, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Flavone acetic acid—Preclinical and clinical activityEuropean Journal of Cancer and Clinical Oncology, 1989